Salesforce, Inc. Website

Salesforce, Inc.

NYSE-CRM

Basic

  • Market Cap

    $264.12B

  • EV

    $263.49B

  • Shares Out

    970M

  • Revenue

    $34.86B

  • Employees

    72,682

Margins

  • Gross

    75.5%

  • EBITDA

    26.45%

  • Operating

    17.21%

  • Pre-Tax

    14.2%

  • Net

    11.87%

  • FCF

    27.25%

Returns (5Yr Avg)

  • ROA

    2.7%

  • ROTA

    5.04%

  • ROE

    4.4%

  • ROCE

    2.43%

  • ROIC

    1.56%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $335.53

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $14.19B

  • Net Debt

    -$632M

  • Debt/Equity

    0.23

  • EBIT/Interest

    206.86

Growth (CAGR)

  • Rev 3Yr

    17.93%

  • Rev 5Yr

    21.28%

  • Rev 10Yr

    23.95%

  • Dil EPS 3Yr

    -1.39%

  • Dil EPS 5Yr

    24.05%

  • Dil EPS 10Yr

    26.83%

  • Rev Fwd 2Yr

    9.7%

  • EBITDA Fwd 2Yr

    9.78%

  • EPS Fwd 2Yr

    16.25%

  • EPS LT Growth Est

    20.5%

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

Select a metric from the list below to chart it

Jan '15

Jan '16

Jan '17

Jan '18

Jan '19

Jan '20

Jan '21

Jan '22

Jan '23

Jan '24

Jan '25 (E)

Jan '26 (E)

Jan '27 (E)

Total Revenues

17,098

21,252

26,492

31,352

34,857

Total Revenues % Chg.

28.7%

24.3%

24.7%

18.3%

11.2%

Cost of Goods Sold, Total

4,235

5,438

7,026

8,360

8,541

Gross Profit

12,863

15,814

19,466

22,992

26,316

Selling General & Admin Expenses, Total

9,634

11,761

14,453

16,079

15,411

R&D Expenses

2,766

3,598

4,465

5,055

4,906

Other Operating Expenses, Total

12,400

15,359

18,918

21,134

20,317

Operating Income

463

455

548

1,858

5,999

Interest Expense, Total

-110

-10

-29

Interest And Investment Income

Net Interest Expenses

-110

-10

-29

Currency Exchange Gains (Loss)

Other Non Operating Income (Expenses)

-18

46

-227

-121

245

EBT, Excl. Unusual Items

445

391

321

1,727

6,215

Restructuring Charges

-828

-988

Gain (Loss) On Sale Of Investments

427

2,170

1,211

-239

-277

Gain (Loss) On Sale Of Assets

Other Unusual Items

-166

EBT, Incl. Unusual Items

706

2,561

1,532

660

4,950

Income Tax Expense

580

-1,511

88

452

814

Earnings From Continuing Operations

126

4,072

1,444

208

4,136

Net Income

126

4,072

1,444

208

4,136

Net Income to Common Incl Extra Items

126

4,072

1,444

208

4,136

Net Income to Common Excl. Extra Items

126

4,072

1,444

208

4,136

Total Shares Outstanding

893

919

989

981

971

Weighted Avg. Shares Outstanding

829

908

955

992

974

Weighted Avg. Shares Outstanding Dil

850

930

974

997

984

EPS

0.2

4.5

1.5

0.2

4.2

EPS Diluted

0.2

4.4

1.5

0.2

4.2

EBITDA

2,598

3,301

3,846

5,644

9,221

Effective Tax Rate

82.2%

-59%

5.7%

68.5%

16.4%